GLP1R and diabetes mellitus: Several classes of drugs, including hypoglycemic, agents renin-angiotensin system (RAS) blockers, sodium-glucose cotransport protein-2 inhibitors (SGLT2i), and glucagon-like peptide-1 receptor (GLP-1R) agonists, have been shown to effectively manage diabetes and DN (5).